Subject: Smallcap Discoveries: ImmunoPrecise Antibodies (NASDAQ: IPA) Update with CEO Jennifer Bath

ImmunoPrecise Antibodies (NASDAQ: IPA) Update with CEO Jennifer Bath
On April 19th we had an update with CEO Jennifer Bath from ImmunoPrecise Antibodies.

ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd. is a biotherapeutic, innovation-powered company that supports its business partners in their quest to discover and develop novel antibodies against a broad range of target classes and diseases. The Company offers a hybrid of services and programs with advanced platforms and technologies — dynamic scientists and business advisors — to optimize antibody discovery and development, against rare and/or challenging epitopes. For further information, visit www.immunoprecise.com.

Video Interview:
After our interviews, we host a Free-For-All session with the live participants to review all things Smallcap Discoveries is following, including updates and commentary companies from both the Select Portfolio and Select Watchlist. 
[[internal_footer]]

    This is an online snapshot of a newsletter created by the owner of Small Cap Premium Service (DJ Dunkerley, 86 East 23rd Ave, v5v 1w9 Vancouver, Canada) and sent via GetResponse on 2022-04-20. Report abuse